borderline significanceP = 0.055
Concurrent use of antiplatelets was a possible protective factor for major amputation with borderline significance (OR, 0.37; 95% CI, 0.13–1.02; P = 0.055).
Concurrent use of antiplatelets was a possible protective factor for major amputation with borderline significance (OR, 0.37; 95% CI, 0.13–1.02; P = 0.055).